The goal of this activity is to ensure that members of the multidisciplinary oncology care team, including physicians, nurses, pharmacists and other relevant health care professionals, have the knowledge and skills necessary to apply the new standards of care for patients with an acute leukemia.
Join Abby Miske, PharmD, BCOP, from Seattle Cancer Care Alliance for this webinar in the 2018 NCCN Pharmacy Update Series on the topic Introduction to the NCCN Guidelines® for Vulvar Cancer and Corresponding Systemic Therapy Recommendations.
Join Sally Barbour, PharmD, BCOP, CPP, FHOPA, from Duke Cancer Institute for this webinar in the 2018 NCCN Pharmacy Update Series on the topic The Evolving Landscape of Immunotherapy and Targeted Therapy for Non-Small Cell Lung Cancer.
Infusion-related HSR to systemic therapy is a serious adverse effect that significantly impacts disease management, quality of life, and life expectancy. Careful assessment of patients prior to initiating systemic therapy would enable the identification of patients at higher risk for HSR.
Occupational exposure to hazardous drugs such as antineoplastic agents is associated with health risks such as those associated with reproductive health and potential increased risk of cancer.
Facebook
Twitter
LinkedIn
Forward
